Patricia J. Eifel, M.D., F.A.C.R., FASTRO

Peer-Reviewed Articles

1. Sammouri J, Venkatesan AM, Lin LL, Jhingran A, Klopp AH, Joyner MM, Eifel PJ, Colbert LE. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement. Gynecol Oncol 180:24-34, 2024. e-Pub 2023. PMID: 38041900.
2. Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, Yoshida-Court K, Napravnik TC, Sammouri J, Lin D, Andring LM, Bronk J, Wu X, Sims TT, Mathew G, Schmeler KM, Eifel PJ, Jhingran A, Lin LL, Joyner MM, Zhang J, Futreal A, Klopp AH, Colbert LE. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy 23(2):123-135, 2024. e-Pub 2023. PMID: 38129211.
3. Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, Bronk JK, Sammouri J, Yanamandra AV, Olvera AV, Carlin LG, Sims T, Delgado Medrano AY, Napravnik TC, O'Hara M, Lin D, Abana CO, Li HX, Eifel PJ, Jhingran A, Joyner M, Lin L, Ramondetta LM, Futreal AM, Schmeler KM, Mathew G, Dorta-Estremera S, Zhang J, Wu X, Ajami NJ, Wong M, Taniguchi C, Petrosino JF, Sastry KJ, Okhuysen PC, Martinez SA, Tan L, Mahmud I, Lorenzi PL, Wargo JA, Klopp AH. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell 41(11):1945-1962.e11, 2023. e-Pub 2023. PMID: 37863066.
4. Gjyshi O, Grippin A, Andring L, Jhingran A, Lin LL, Bronk J, Eifel PJ, Joyner MM, Sastry JK, Yoshida-Court K, Solley TN, Napravnik TC, O'Hara MP, Hegde VL, Colbert LE, Klopp AH. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer. Clin Transl Radiat Oncol 39:100578, 2023. e-Pub 2023. PMID: 36935860.
5. Andring LM, Corrigan KL, Rooney M, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Kazantsev T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. Patient reported outcomes for women undergoing definitive chemoradiation for gynecologic cancer: A prospective clinical trial. Pract Radiat Oncol 13(6):e538-e546, 2023. e-Pub 2023. PMID: 37597615.
6. Karpinets TV, Wu X, Solley T, El Alam MB, Sims TT, Yoshida-Court K, Lynn E, Ahmed-Kaddar M, Biegert G, Yue J, Song X, Sun H, Petrosino JF, Mezzari MP, Okhuysen P, Eifel PJ, Jhingran A, Lin LL, Schmeler KM, Ramondetta L, Ajami N, Jenq RR, Futreal A, Zhang J, Klopp AH, Colbert LE. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure. BMC Cancer 22(1):945, 2022. e-Pub 2022. PMID: 36050658.
7. Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, Eifel PJ, Colbert LE, Lu KH, Klopp AH. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol 164(3):550-557, 2022. e-Pub 2021. PMID: 34974906.
8. Colbert LE, El MB, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
9. Lakomy DS, Wu J, Chapman BV, Yu ZH, Lee B, Klopp AH, Jhingran A, Eifel PJ, Lin LL. Use of specific duodenal dose constraints during treatment planning reduces toxicity after definitive para-aortic radiotherapy for cervical cancer. Pract Radiat Oncol 12(3):e207-e215, 2022. e-Pub 2021. PMID: 34958984.
10. Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol 12(5):e423-e433, 2022. e-Pub 2022. PMID: 35390531.
11. Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys 109(2):413-424, 2021. e-Pub 2020. PMID: 32905846.
12. Armbruster SD, Fellman BM, Jhingran A, Eifel PJ, Klopp AH, Coleman RL, Ramondetta LM, Frumovitz M. A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer 29(1):213-222, 2021. e-Pub 2020. PMID: 32338316.
13. El Alam MB, Sims TT, Kouzy R, Biegert GWG, Jaoude JABI, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One 16(3):e0247905, 2021. e-Pub 2021. PMID: 33662003.
14. Salcedo MP, Sood AK, Jhingran A, Eifel PJ, Klopp AH, Iyer RB, Fellman BM, Jimenez C, Schmeler KM. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer 126(11):2607-2613, 2020. e-Pub 2020. PMID: 32125711.
15. Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin L, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 107(1):163-171, 2020. e-Pub 2020. PMID: 31987960.
16. Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy 19(4):427-437, 2020. e-Pub 2019. PMID: 31786169.
17. Ning MS, Vedam S, Ma J, Stafford RJ, Bruno TL, Cunningham M, Starks C, Lawyer A, Venkatesan AM, Wang L, Wang J, Olivieri ND, Guzman AB, Incalcaterra JR, Thaker NG, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies. Brachytherapy 19(3):305-315, 2020. e-Pub 2020. PMID: 32265119.
18. Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17(11):1374-1391, 2019. PMID: 31693991.
19. Klopp AH, Eifel PJ. IMRT all the way. Int J Radiat Oncol Biol Phys 105(4):692-693, 2019. PMID: 31655653.
20. Eifel PJ. High intermediate risk endometrial cancer. What is it?. Int J Gynecol Cancer 29(7):1084-1085, 2019. PMID: 31474586.
21. Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol 154(1):22-28, 2019. e-Pub 2019. PMID: 31109659.
22. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17(1):64-84, 2019. PMID: 30659131.
23. Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy 18(4):445-452, 2019. e-Pub 2019. PMID: 30992185.
24. Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys 102(3):593-600, 2018. e-Pub 2018. PMID: 30017792.
25. Stecklein SR, Frumovitz M, Klopp AH, Gunther JR, Eifel PJ. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol 148(3):474-479, 2018. e-Pub 2018. PMID: 29336837.
26. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(2):170-199, 2018. PMID: 29439178.
27. Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma. Int J Gynecol Cancer 28(1):114-121, 2018. e-Pub 2017. PMID: 28930812.
28. Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol 148(1):132-138, 2018. e-Pub 2017. PMID: 29089122.
29. Swanick CW, Eifel PJ, Huo J, Meyer LA, Smith GL. Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecol Oncol 146(1):87-93, 2017. e-Pub 2017. PMID: 28506563.
30. Eifel PJ. Role of radiation therapy. Best Pract Res Clin Obstet Gynaecol 41:118-125, 2017. e-Pub 2016. PMID: 27986398.
31. Swanick CW, Eifel PJ, Klopp AH. In Reply to Mazeron et al. Int J Radiat Oncol Biol Phys 97(3):639, 2017. PMID: 28126311.
32. Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Pract Radiat Oncol 7(3):e165-e173, 2017. e-Pub 2016. PMID: 27743802.
33. Viswanathan AN, Erickson BA, Ibbott GS, Small W, Eifel PJ. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. Brachytherapy 16(1):68-74, 2017. PMID: 28109633.
34. Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J. Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15(1):92-120, 2017. PMID: 28040721.
35. Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol 143(3):552-557, 2016. e-Pub 2016. PMID: 27645621.
36. Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 96(4):793-800, 2016. e-Pub 2016. PMID: 27788952.
37. Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W. Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. Int J Radiat Oncol Biol Phys 95(4):1191-1200, 2016. e-Pub 2016. PMID: 27130794.
38. Eifel PJ. Guidelines for endometrial cancer management: finding order amid the uncertainties. Ann Oncol 27(2):212-213, 2016. e-Pub 2015. PMID: 26658892.
39. Callegaro-Filho D, Gershenson DM, Nick AM, Munsell MF, Ramirez PT, Eifel PJ, Euscher ED, Marques RM, Nicolau SM, Schmeler KM. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases. Gynecol Oncol 140(1):53-57, 2016. e-Pub 2015. PMID: 26546963.
40. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL, National Comprehensive Cancer Network. Uterine Sarcoma, Version 1.2016. J Natl Compr Canc Netw 13(11):1321-31, 2015. PMID: 26553763.
41. Ho JC, Allen PK, Jhingran A, Westin SN, Lu KH, Eifel PJ, Klopp AH. Management of nodal recurrences of endometrial cancer with IMRT. Gynecol Oncol 139(1):40-6, 2015. e-Pub 2015. PMID: 26193429.
42. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet 131 Suppl 2:S76-83, 2015. PMID: 26433678.
43. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vagina. Int J Gynaecol Obstet 131 Suppl 2:S84-7, 2015. PMID: 26433679.
44. Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH. Isolated Port-Site Metastases After Minimally Invasive Hysterectomy for Endometrial Cancer: Outcomes of Patients Treated With Radiotherapy. Int J Gynecol Cancer 25(5):869-74, 2015. e-Pub 2015. PMID: 25790043.
45. Smith GL, Jiang J, Giordano SH, Meyer LA, Eifel PJ. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiat Oncol Biol Phys 92(2):260-7, 2015. PMID: 25968823.
46. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Teng N, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL. Cervical cancer, version 2.2015. J Natl Compr Canc Netw 13(4):395-404, 2015. PMID: 25870376.
47. Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, Wazer DE. Where Have You Gone, Brachytherapy?. J Clin Oncol 33(9):980-2, 2015. e-Pub 2015. PMID: 25667278.
48. Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system?. Gynecol Oncol 136(2):269-73, 2015. e-Pub 2014. PMID: 25524458.
49. Fleming ND, Frumovitz M, Schmeler KM, dos Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN, Ramirez PT. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol 136(1):48-53, 2015. e-Pub 2014. PMID: 25451695.
50. Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJ. Relationship Between Low Hemoglobin Levels and Outcomes After Treatment With Radiation or Chemoradiation in Patients With Cervical Cancer: Has the Impact of Anemia Been Overstated?. Int J Radiat Oncol Biol Phys 91(1):196-205, 2015. e-Pub 2014. PMID: 25446609.
51. Callegaro-Filho D, Burke TW, Eifel PJ, Ramirez PT, Euscher EE, Schmeler KM. Radiotherapy for recurrent small cell carcinoma of the ovary: A case report and review of the literature. Gynecol Oncol Rep 11:23-25, 2015. e-Pub 2014. PMID: 26076089.
52. Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer. Brachytherapy 14(3):385-9, 2015. e-Pub 2015. PMID: 25620163.
53. Salcedo MP, Milbourne AM, Jhingran A, Eifel PJ, Ramirez PT, Schmeler KM. High-grade cervical dysplasia following radiation therapy for invasive cervical cancer: A report of four cases. Case Rep Oncol 8(2):217-21, 2015. e-Pub 2015. PMID: 26078740.
54. Chi G CHL, Young A, McFarlane J, Watson M, Coleman RL, Eifel PJ, LoBiondo-Wood G, Bodurka DC, Richardson M. Effects of music relaxation video on pain and anxiety for women with gynaecological cancer receiving intracavitary brachytherapy: a randomised controlled trial. Journal of Research in Nursing 20(2):129-144, 2015.
55. Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol 124(6):1098-104, 2014. PMID: 25415160.
56. Dayyani F, Hoffman K, Eifel P, Guo C, Vikram R, Pagliaro LC, Pettaway C. Management of advanced primary urethral carcinomas. BJU Int 114(1):25-31, 2014. e-Pub 2014. PMID: 24447439.
57. Eifel PJ, Ho A, Khalid N, Erickson B, Owen J. Patterns of Radiation Therapy Practice for Patients Treated for Intact Cervical Cancer in 2005 to 2007: A Quality Research in Radiation Oncology Study. Int J Radiat Oncol Biol Phys 89(2):249-56, 2014. e-Pub 2014. PMID: 24411621.
58. Tanderup K, Eifel PJ, Yashar CM, Pötter R, Grigsby PW. Curative Radiation Therapy for Locally Advanced Cervical Cancer: Brachytherapy Is NOT Optional. Int J Radiat Oncol Biol Phys 88(3):537-9, 2014. e-Pub 2014. PMID: 24411631.
59. Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric Predictors of Duodenal Toxicity After Intensity Modulated Radiation Therapy for Treatment of the Para-aortic Nodes in Gynecologic Cancer. Int J Radiat Oncol Biol Phys 88(2):357-62, 2014. PMID: 24411609.
60. Smith GL, Eifel PJ. In Regard to Han et al. Int J Radiat Oncol Biol Phys 88(2):459-60, 2014. PMID: 24411614.
61. Christensen EN, Yu HZ, Klopp AH, Tsai JC, Lawyer AA, Court LE, Eifel PJ. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer. Brachytherapy 13(3):240-9, 2014. e-Pub 2013. PMID: 24188993.
62. Thomadsen BR, Erickson BA, Eifel PJ, Hsu IC, Patel RR, Petereit DG, Fraass BA, Rivard MJ. A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary. Pract Radiat Oncol 4(2):65-70, 2014. e-Pub 2014. PMID: 24890345.
63. Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecol Oncol 131(3):645-9, 2013. e-Pub 2013. PMID: 23643871.
64. Likhacheva A, Jhingran A, Bodurka DC, Sun C, Sam M, Eifel PJ. Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly Cisplatin or every-3-week Cisplatin and 5-Fluorouracil. Int J Gynecol Cancer 23(8):1520-7, 2013. PMID: 24257567.
65. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-Field Radiation Therapy for Locoregionally Recurrent Ovarian Cancer. Gynecol Oncol 130(2):300-305, 2013. e-Pub 2013. PMID: 23648467.
66. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol 129(2):304-9, 2013. e-Pub 2013. PMID: 23385150.
67. Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp A. Anatomic Distribution of Fluorodeoxyglucose-Avid Para-aortic Lymph Nodes in Patients With Cervical Cancer. Int J Radiat Oncol Biol Phys 85(4):1045-50, 2013. e-Pub 2013. PMID: 23332221.
68. Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [18F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol 3(1):45-53, 2013. e-Pub 2012. PMID: 24674263.
69. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, Dupont N, Eifel PJ, Gaffney DK, Giuntoli RL 2nd, Han E, Huh WK, Lurain JR 3rd, Martin L, Morgan MA, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Tillmanns T, Valea FA, McMillian NR, Hughes M.. Cervical Cancer. J Natl Compr Canc Netw 11(3):320-43, 2013. PMID: 23486458.
70. Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol 3(2):115-123, 2013. e-Pub 2012. PMID: 24674314.
71. Shirvani SM, Klopp AH, Likhacheva A, Jhingran A, Soliman PT, Lu KH, Eifel PJ. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol 3(1):e21-8, 2013. e-Pub 2012. PMID: 24674269.
72. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vagina. Int J Gynaecol Obstet 119(Suppl 2):S97-99, 2012. PMID: 22999510.
73. Mikell JK, Klopp AH, Gonzalez GM, Kisling KD, Price MJ, Berner PA, Eifel PJ, Mourtada F. Impact of heterogeneity-based dose calculation using a deterministic grid-based boltzmann equation solver for intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 83(3):e417-22, 2012. e-Pub 2012. PMID: 22436788.
74. Gaffney D, Mundt A, Schwarz J, Eifel P. Advances in clinical research in gynecologic radiation oncology: An RTOG symposium. Int J Gynecol Cancer 22(4):667-74, 2012. e-Pub 2012. PMID: 22398709.
75. Costales AB, Eifel PJ, Deavers MT, Frumovitz M, Schmeler KM. Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix. Gynecol Oncol Reports 2:97-99. e-Pub 2012.
76. Kelly P, Das P, Varadhachary GR, Fontanilla HP, Krishnan S, Delclos ME, Jhingran A, Eifel PJ, Crane CH. Role of Definitive Radiation Therapy in Carcinoma of Unknown Primary in the Abdomen and Pelvis. Int J Radiat Oncol Biol Phys 82(5):2012-7, 2012. e-Pub 2011. PMID: 21640510.
77. Klopp AH, Eifel PJ. Biological predictors of cervical cancer response to radiation therapy. Semin Radiat Oncol 22(2):143-150, 2012. PMID: 22385921.
78. Jhingran A, Salehpour M, Sam M, Levy L, Eifel PJ. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys 82(1):256-62, 2012. e-Pub 2010. PMID: 21093170.
79. Lee LJ, Das IJ, Higgins SA, Jhingran A, Small W, Thomadsen B, Viswanathan AN, Wolfson A, Eifel P. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy 11(1):53-7, 2012. PMID: 22265438.
80. Small W, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Los Santos JF, Viswanathan AN, Gaffney D. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy 11(1):58-67, 2012. PMID: 22265439.
81. Costales AB, Eifel PJ, Deavers MT, Frumovitz M, Schmeler KM. Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix. Gynecol Oncol Case Rep 2(3):97-9, 2012. e-Pub 2012. PMID: 24371632.
82. Eifel PJ. Regional treatment of vulvar cancer; lessons from the past and lessons for the future. Pract Radiat Oncol 2(4):279-81, 2012. e-Pub 2012. PMID: 24674165.
83. Xiao Y, Bernstein Kde A, Chetty IJ, Eifel P, Hughes L, Klein EE, McDermott P, Prisciandaro J, Paliwal B, Price RA, Werner-Wasik M, Palta JR, Ad Hoc Committee on Teaching Physics to Residents and Invitees. The American Society for Radiation Oncology's 2010 Core Physics Curriculum for Radiation Oncology Residents. Int J Radiat Oncol Biol Phys 81(4):1190-1192, 2011. e-Pub 2010. PMID: 21035958.
84. Klopp AH, Eifel PJ. Chemoradiotherapy for cervical cancer in 2010. Curr Oncol Rep 13(1):77-85, 2011. e-Pub 2010. PMID: 21042887.
85. Fisher CM, Fortenberry BR, Jhingran A, Eifel PJ. Novel technique for simulation and external beam treatment planning for obese patients. Pract Radiat Oncol 1(3):152-155, 2011. e-Pub 2011. PMID: 24673944.
86. Garg AK, Jhingran A, Klopp AH, Aggarwal BB, Kunnumakkara AB, Broadus RR, Eifel PJ, Buchholz TA. Expression of nuclear transcription factor Kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys 78(5):1331-6, 2010. e-Pub 2010. PMID: 20231067.
87. Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PT. Primary malignant melanoma of the vagina. Obstet Gynecol 116(6):1358-65, 2010. PMID: 21099603.
88. Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, Dupont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA. Cervical cancer. J Natl Compr Canc Netw 8(12):1388-416, 2010. PMID: 21147903.
89. Eifel PJ. Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment. Nat Rev Clin Oncol 7(10):553-4, 2010. PMID: 20877416.
90. Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ. Patterns of Regional Recurrence After Definitive Radiotherapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 76(5):1396-403, 2010. e-Pub 2009. PMID: 19581056.
91. Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 76(3 Suppl):S116-22, 2010. PMID: 20171505.
92. Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: implications for Survivors. Cancer 116(3):625-630, 2010. e-Pub 2010. PMID: 20052724.
93. Price MJ, Kry SF, Eifel PJ, Salehpour M, Mourtada F. Dose Perturbation due to the Polysulfone Cap Surrounding a Fletcher-Williamson Colpostat. J Appl Clin Med Phys 11(1):68-76, 2010. PMID: 20160700.
94. Price MJ, Jackson EF, Gifford KA, Eifel PJ, Mourtada F. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging. Med Phys 36(12):5515-24, 2009. PMID: 20095264.
95. Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 115(1):6-11, 2009. e-Pub 2009. PMID: 19632709.
96. Price MJ, Gifford KA, Horton JL, Eifel PJ, Gillin MT, Lawyer AA, Mourtada F. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer. Med Phys 36(9):4147-55, 2009. PMID: 19810488.
97. Holmes T, Das R, Low D, Yin FF, Balter J, Palta J, Eifel P. American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments. Int J Radiat Oncol Biol Phys 74(5):1311-8, 2009. PMID: 19616738.
98. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter?. Int J Gynecol Cancer 19(6):1107-12, 2009. PMID: 19820377.
99. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos SM, Cho KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jaggernauth W, Kapp DS, Kavanagh JJ, Lurain JR, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W, Teng N. Uterine neoplasms. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7(5):498-531, 2009. PMID: 19460278.
100. Eifel PJ. Studies of adjuvant treatment for endometrial cancer. Oncology (Williston Park) 23(4):364-5, 2009. PMID: 19476266.
101. Beadle BM, Jhingran A, Salehpour M, Sam M, Iyer RB, Eifel PJ. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 73(1):235-41, 2009. e-Pub 2008. PMID: 18513882.
102. Eifel PJ, Jhingran A, Levenback CF, Tucker S. Predictive value of a proposed subclassification of Stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer 19(1):2-7, 2009. PMID: 19258933.
103. Gifford KA, Wareing T, Failla G, Horton J, Eifel P, Mourtada F. Comparison of a 3-D multi-group SN particle transport code with Monte Carlo for intracavitary brachytherapy of the cervix uteri. J Appl Clin Med Phys 11(1):3103, 2009. PMID: 20160682.
104. McGuire SE, Frank SJ, Eifel PJ. Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy. Brachytherapy 7(4):359-63, 2008. e-Pub 2008. PMID: 18778972.
105. Tripuraneni P, Watson RL, Ang KK, Harrison L, Eifel P, Zietman A, Haffty B, Thevenot LI, Willett CG, Schomberg PJ, Pickles T, Halberg FE, Devlin PM. Intersociety Radiation Oncology Summit-SCOPE II. Int J Radiat Oncol Biol Phys 72(2):323-6, 2008. PMID: 18793951.
106. Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene Expression Changes in Cervical Squamous Cell Carcinoma after Initiation of Chemoradiation and Correlation with Clinical Outcome. Int J Radiat Oncol Biol Phys 71(1):226-36, 2008. PMID: 18406887.
107. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys 70(1):118-125, 2008. e-Pub 2007. PMID: 17869451.
108. Wolfson AH, Winter K, Crook W, Krishan A, Grigsby PW, Markoe AM, Morris M, Gaffney DK, Eifel PJ, Lucci JA. Are increased tumor sneuploidy and heightened Cell Proliferation Along With Heterogeneity Associated With Patient Outcome for Carcinomas of the Uterine Cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial. Int J Radiat Oncol Biol Phys 70(1):111-117, 2008. e-Pub 2007. PMID: 17919835.
109. Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Small W, Greven K. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys 69(1):111-7, 2007. e-Pub 2007. PMID: 17482376.
110. Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Greven K. A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys 67(1):104-9, 2007. e-Pub 2006. PMID: 17084549.
111. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470-474, 2007. e-Pub 2007. PMID: 17292459.
112. Mourtada F, Gifford KA, Berner PA, Horton JL, Price MJ, Lawyer AA, Eifel PJ. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids. Med Dosim 32(3):181-187, 2007. PMID: 17707197.
113. Pothuri B, Ramondetta L, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers. Gynecol Oncol 103(3):948-51, 2006. e-Pub 2006. PMID: 16870239.
114. Price MJ, Gifford KA, Horton J, Lawyer A, Eifel P, Mourtada F. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study. Phys Med Biol 51(16):4083-94, 2006. e-Pub 2006. PMID: 16885626.
115. Klopp AH, Eifel PJ. Gene expression profiling in cervical cancer: state of the art and future directions. Cancer J 12(3):170-174, 2006. PMID: 16803672.
116. Eifel PJ, Jhingran A, Brown J, Levenback C, Thames H. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer 16(3):1106-11, 2006. PMID: 16803493.
117. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, 3rd, Morgan RJ, Jr, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W, Jr, Soper J, Teng N. Uterine cancers. J Natl Compr Canc Netw 4(5):438-62, 2006. PMID: 16687093.
118. Eifel PJ. Chemoradiotherapy for cervical cancer: what next?. J Clin Oncol 23(33):8277-9, 2005. e-Pub 2005. PMID: 16230671.
119. Price MJ, Horton JL, Gifford KA, Eifel PJ, Jhingran A, Lawyer AA, Berner PA, Mourtada F. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo study. Phys Med Biol 50(21):5075-87, 2005. e-Pub 2005. PMID: 16237242.
120. Gifford KA, Horton JL, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 63(2):615-21, 2005. PMID: 16168853.
121. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428-36, 2005. PMID: 16234510.
122. Ahamad A, D'Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, Eifel PJ. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62(4):1117-24, 2005. PMID: 15990017.
123. Bristol I, Brown J, Slomovitz BM, Shannon VR, Eifel PJ. Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: a case report. Gynecol Oncol 97(3):953-6, 2005. PMID: 15907987.
124. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer 15(3):510-6, 2005. PMID: 15882178.
125. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62(1):131-7, 2005. PMID: 15850913.
126. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62(1):138-147, 2005. PMID: 15850914.
127. D'Souza WD, Ahamad AA, Iyer RB, Salehpour MR, Jhingran A, Eifel PJ. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 61(4):1062-70, 2005. PMID: 15752885.
128. Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J.. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): A patterns of care study. Int J Radiat Oncol Biol Phys 63(4):1083-92, 2005. e-Pub 2005. PMID: 16099599.
129. Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. Int J Radiat Oncol Biol Phys 60(4):1144-53, 2004. PMID: 15519786.
130. Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Synchronous primary cancers of the endometrium and ovary: A single institution review of 84 cases. Gynecol Oncol 94(2):456-62, 2004. PMID: 15297188.
131. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93(1):27-33, 2004. PMID: 15047210.
132. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22(5):872-80, 2004. PMID: 14990643.
133. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 58(3):786-96, 2004. PMID: 14967435.
134. Frumovitz M, Ramirez PT, Tortolero-Luna G, Malpica A, Eifel P, Burke TW, Levenback C. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol 92(1):205-10, 2004. PMID: 14751159.
135. Eifel PJ. Accurate diagnosis of regional metastasis from cervical cancer: is PET the answer?. Int J Radiat Oncol Biol Phys 59(3):637-8, 2004. PMID: 15183466.
136. Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 91(3):463-9, 2003. PMID: 14675663.
137. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 57(2):409-18, 2003. PMID: 12957252.
138. Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56(5):1366-72, 2003. PMID: 12873682.
139. Munkarah AR, Jhingran A, Iyer RB, Wallace S, Eifel PJ, Gershenson D, Burke TW. Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer 12(6):755-9, 2002. PMID: 12445255.
140. Grigsby P, Winter K, Komaki R, Marcial V, Eifel P, Doncals D, Stevens R, Rotman M, Gaffney D. Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 54(1):51-7, 2002. PMID: 12182974.
141. Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20(17):3651-7, 2002. PMID: 12202666.
142. Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 51(4):982-7, 2001. PMID: 11704321.
143. Ramirez PT, Levenback C, Burke TW, Eifel P, Wolf JK, Gershenson DM. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol 82(1):150-5, 2001. PMID: 11426977.
144. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93:979-89, 2001. PMID: 11438563.
145. Greven KM, Levenback C, Chao CK, Delaney T, Del Priore G, Eifel P, Erickson BA, Followill D, Gaffney D, Garcia M, Gerszten K, Grigsby P, Henderson R, Hricak H, Hsu J, Jhingran A, Kaye A, Kudelka A, Lukka H, Mutch D, Nag S, Rotman M, Shefter T, Smith W, Stehman F, Souhami L, Wenzel L, Winter KA, Wolfson A. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. Int J Radiat Oncol Biol Phys 51(3, Suppl 2):58-9, 2001. PMID: 11641017.
146. Katz A, Eifel PJ. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48(5):1417-25, 2000. PMID: 11121642.
147. Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, Wharton JT. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 78(2):187-93, 2000. PMID: 10926801.
148. Katz A, Eifel PJ, Moughan J, Owen JB, Mahon I, Hanks GE. Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study. Int J Radiat Oncol Biol Phys 47(2):443-50, 2000. PMID: 10802372.
149. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix. Int J Radiat Oncol Biol Phys 46(5):1177-83, 2000. PMID: 10725629.
150. Chaney AW, Eifel PJ, Logsdon MD, Morris M, Wharton JT. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 45(1):113-8, 1999. PMID: 10477014.
151. Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C, Gershenson DM. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol 73(1):35-41, 1999. PMID: 10094877.
152. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340(15):1137-43, 1999. PMID: 10202164.
153. Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43(4):763-75, 1999. PMID: 10098431.
154. Eifel PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study. Int J Radiat Oncol Biol Phys 43(2):351-8, 1999. PMID: 10030261.
155. Ijaz T, Eifel PJ, Burke T, Oswald MJ. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol 70(2):241-6, 1998. PMID: 9740698.
156. Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys 41(4):817-22, 1998. PMID: 9652843.
157. Morris M, Eifel PJ. An interesting observation in a retrospective review of 171 women treated for cervical cancer with radical hysterectomy. Gynecol Oncol 67(3):328-9, 1997. PMID: 9441784.
158. Eifel PJ. Intracavitary brachytherapy in the treatment of gynecologic neoplasms. J Surg Oncol 66(2):141-7, 1997. PMID: 9354174.
159. Canpolat C, Evans HL, Corpron C, Andrassy RJ, Chan K, Eifel P, Elidemir O, Raney B. Fibromyxoid sarcoma in a four-year-old child: case report and review of the literature. Med Pediatr Oncol 27(6):561-4, 1996. PMID: 8888818.
160. Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R. Combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 34(6):1022-9, 1996. PMID: 8647968.
161. Ripley D, Levenback C, Eifel P, Lewis RM. Adenocarcinoma of the cervix in a renal transplant patient. Gynecol Oncol 59(1):151-5, 1995. PMID: 7557603.
162. Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DM. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol 59(1):51-6, 1995. PMID: 7557615.
163. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 59(1):38-44, 1995. PMID: 7557613.
164. Wheeler JA, Stephens LC, Tornos C, Eifel PJ, Ang KK, Milas L, Allen PK, Meyn RE. ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 32(5):1487-93, 1995. PMID: 7635794.
165. Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32(5):1289-300, 1995. PMID: 7635768.
166. Gabel C, Eifel PJ, Tornos C, Burke TW. Radiation recall reaction to idarubicin resulting in vaginal necrosis. Gynecol Oncol 57(2):266-9, 1995. PMID: 7729748.
167. Morris M, Eifel PJ, Burke TW, McNamara MM, Levenback C, Kavanagh JJ, Gershenson DM. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol 57(1):72-8, 1995. PMID: 7705704.
168. Grigsby PW, Russell A, Bruner D, Eifel P, Koh WJ, Spanos W, Stetz J, Stitt JA, Sullivan J. Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys 31(5):1281-99, 1995. PMID: 7713788.
169. Eifel PJ, Donaldson SS, Thomas PR. Response of growing bone to irradiation: a proposed late effects scoring system. Int J Radiat Oncol Biol Phys 31(5):1301-7, 1995. PMID: 7713789.
170. McIntyre JF, Eifel PJ, Levenback C, Oswald MJ. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer 75(3):836-43, 1995. PMID: 7828135.
171. Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DM. Preoperative continuous infusion cisplatinum and 5-fluorouracil with radiation for locally advanced or recurrent carcinoma of the vulva. Gynecol Oncol 59:51-56, 1995.
172. Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol 55(2):206-10, 1994. PMID: 7959285.
173. Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol 55(1):29-35, 1994. PMID: 7959262.
174. Auger M, Raney B, Callender D, Eifel P, Ordóñez NG. Metastatic intracranial chordoma in a child with massive pulmonary tumor emboli. Pediatr Pathol 14(5):763-70, 1994. PMID: 7808974.
175. Komaki R, Pajak TF, Marcial VA, Rotman M, Grigsby PW, Leibel SA, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. Phase I/II study of the Radiation Therapy Oncology Group 88-05. Cancer 73(10):2619-25, 1994. PMID: 8174061.
176. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29(1):9-16, 1994. PMID: 8175451.
177. Levenback C, Gershenson DM, McGehee R, Eifel PJ, Morris M, Burke TW. Enterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol 52(3):296-300, 1994. PMID: 8157186.
178. Eifel PJ. Can patients with regional metastases from carcinoma of the endometrium be cured with radiation therapy?. Front Radiat Ther Oncol 28:196-203, 1994. PMID: 7982597.
179. Eifel PJ, Thoms WW, Smith TL, Morris M, Oswald MJ. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 28(1):113-8, 1994. PMID: 8270431.
180. Wagner LK, Eifel PJ, Geise RA. Potential biological effects following high X-ray dose interventional procedures. J Vasc Interv Radiol 5(1):71-84, 1994. PMID: 8136601.
181. Coleman RL, Burke TW, Morris M, Eifel PJ, Hallum AV, Wallace S, Tornos C. Intraoperative radiographs to confirm the adequacy of lymph node resection in patients with suspicious lymphangiograms. Gynecol Oncol 51(3):362-367, 1993. PMID: 8112646.
182. Kupelian PA, Eifel PJ, Tornos C, Burke TW, Delclos L, Oswald MJ. Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys 27(4):817-24, 1993. PMID: 8244810.
183. Roman LD, Morris M, Mitchell MF, Eifel PJ, Burke TW, Atkinson EN. Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol 50(2):179-84, 1993. PMID: 8375732.
184. Patton TJ, Follen Mitchell M, Neely Atkinson E, Eifel P, Gastorf L, Yancey C, Miller D, Wharton JT. Parameters of small bowel dysfunction in cervical cancer patients undergoing radiotherapy. Int J Gynecol Cancer 3(3):175-182, 1993. PMID: 11578340.
185. Matthews CM, Burke TW, Tornos C, Eifel PJ, Atkinson EN, Stringer CA, Morris M, Silva EG. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol 49(1):19-23, 1993. PMID: 8482554.
186. Eifel PJ. Radiotherapy versus radical surgery for gynecologic neoplasms: carcinomas of the cervix and vulva. Front Radiat Ther Oncol 27:130-42, 1993. PMID: 8504941.
187. Morris M, Gershenson DM, Eifel P, Silva EG, Mitchell MF, Burke TW, Wharton JT. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol 47(1):62-5, 1992. PMID: 1330847.
188. Roman LD, Morris M, Eifel PJ, Burke TW, Gershenson DM, Wharton JT. Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix. Obstet Gynecol 79(4):485-9, 1992. PMID: 1553163.
189. Thoms WW, Eifel PJ, Smith TL, Morris M, Delclos L, Wharton JT, Oswald MJ. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 23(3):491-9, 1992. PMID: 1612949.
190. Kavadi VS, Eifel PJ. FIGO stage IIIA carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 24(2):211-5, 1992. PMID: 1526857.
191. Starkschall G, Eifel PJ. An interactive beam-weight optimization tool for three-dimensional radiotherapy treatment planning. Med Phys 19(1):155-63, 1992. PMID: 1620041.
192. Eifel PJ, Gershenson DM, Delclos L, Wharton JT, Peters LJ. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma. Int J Radiat Oncol Biol Phys 21(4):1013-8, 1991. PMID: 1917596.
193. Eifel PJ, Burke TW, Delclos L, Wharton JT, Oswald MJ. Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol 41(3):199-205, 1991. PMID: 1869095.
194. Belli JA, Eifel PJ, Menache L, Kennamer D. Twice-daily anesthesia in children. Int J Radiat Oncol Biol Phys 20(4):909-10, 1991. PMID: 2004975.
195. Mitchell MF, Gershenson DM, Soeters RP, Eifel PJ, Delclos L, Wharton JT. The long-term effects of radiation therapy on patients with ovarian dysgerminoma. Cancer 67(4):1084-90, 1991. PMID: 1991256.
196. Eifel PJ, Sampson CM, Tucker SL. Radiation fractionation sensitivity of epiphyseal cartilage in a weanling rat model. Int J Radiat Oncol Biol Phys 19(3):661-4, 1990. PMID: 2211212.
197. Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer 65(11):2507-14, 1990. PMID: 2337867.
198. Menache L, Eifel PJ, Kennamer DL, Belli JA. Twice-daily anesthesia in infants receiving hyperfractionated irradiation. Int J Radiat Oncol Biol Phys 18(3):625-9, 1990. PMID: 2318696.
199. Eifel PJ, McClure S. Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring. Int J Radiat Oncol Biol Phys 17(4):907-8, 1989. PMID: 2476427.
200. Eifel PJ. Decreased bone growth arrest in weanling rats with multiple radiation fractions per day. Int J Radiat Oncol Biol Phys 15(1):141-5, 1988. PMID: 3391810.
201. Eifel PJ, Cassady JR, Belli JA. Radiation therapy of tumors of the brainstem and midbrain in children: experience of the Joint Center for Radiation Therapy and Children's Hospital Medical Center (1971-1981). Int J Radiat Oncol Biol Phys 13(6):847-52, 1987. PMID: 3583855.
202. Eifel PJ, Brown JM. Pharmacokinetics and toxicology of continuously infused nitroimidazoles. Int J Radiat Oncol Biol Phys 10(8):1311-4, 1984. PMID: 6236186.
203. Ross JC, Eifel PJ, Cox RS, Kempson RL, Hendrickson MR. Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 7(8):715-29, 1983. PMID: 6318581.
204. Eifel PJ, Brown DM, Lee WW, Brown JM. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine. Int J Radiat Oncol Biol Phys 9(10):1513-9, 1983. PMID: 6629891.
205. Eifel PJ, Ross J, Hendrickson M, Cox RS, Kempson R, Martinez A. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons. Cancer 52(6):1026-31, 1983. PMID: 6883271.
206. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 50(1):163-70, 1982. PMID: 7083121.
207. Hendrickson M, Ross J, Eifel PJ, Cox RS, Martinez A, Kempson R. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol 13(3):373-92, 1982. PMID: 6284595.
208. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6(2):93-108, 1982. PMID: 7102898.
209. Brown SB, Brant-Zawadzki M, Eifel P, Coleman CN, Enzmann DR. CT of irradiated solid tumor metastases to the brain. Neuroradiology 23(3):127-31, 1982. PMID: 7088282.
210. Eifel P, Billingsley A, Lucas ZJ. Rapid killing of viral-infected L cells by alpha-lymphotoxin. Cell Immunol 47(1):197-203, 1979. PMID: 228866.
211. Eifel PJ, Walker SM, Lucas ZJ. Standardization of a sensitive and rapid assay for lymphotoxin. Cell Immunol 15(1):208-21, 1975. PMID: 45839.

Invited Articles

1. Eifel PJ. The value of pelvic radiation therapy after hysterectomy for early endometrial cancer. Oncology (Williston Park) 27(10):990-999, 2013. PMID: 24367856.
2. Eifel PJ. Studies of adjuvant treatment for endometrial cancer (The Diavolitis/Boyle/Singh et al Article Reviewed). Oncology 23(4):364-365, 2009.
3. Eifel PJ. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer. Nat Clin Pract Oncol 3(5):248-55, 2006. PMID: 16683003.
4. Eifel PJ. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol 16(3):177-86, 2006. PMID: 16814159.
5. Stehman FB, Rose PG, Greer BE, Roy M, Plante M, Penalver M, Jhingran A, Eifel P, Montz F, Wharton JT. Innovations in the treatment of invasive cervical cancer. Cancer 98(Suppl 9):2052-63, 2003. PMID: 14603542.
6. Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol 180(6):1621-31, 2003. PMID: 12760933.
7. Eifel PJ. The Kim/Alvarez/Omura Article Reviewed. [referring to Kim, et al. Advances in the treatment of gynecologic malignancies. Part I: Cancers of the cervix and vulva]. Oncol 16:1528-1530, 2002.
8. Rose PG, Eifel PJ. Combined radiation therapy and chemotherapy for carcinoma of the cervix. Cancer J 7(2):86-94, 2001. PMID: 11324770.
9. Eifel PJ. Chemoradiation for carcinoma of the cervix: advances and opportunities. Radiat Res 154(3):229-36, 2000. PMID: 11012341.
10. Eifel PJ Rose PG. Chemotherapy and radiation therapy for cervical cancer. ASCO Educational Book:199-206, 2000.
11. Rose PG Eifel PJ. Combined modality treatment for carcinoma of the cervix. Principles and Practice of Oncology Updates No. 6 14:1-10, 2000.
12. Logsdon MD, Eifel PJ. Low dose rate brachytherapy in the treatment of cervical carcinoma. Hematol Oncol Clin North Am 13(3):577-84, 1999. PMID: 10432430.
13. Eifel PJ. Is there a role for neoadjuvant chemotherapy in the treatment of locally advanced carcinoma of the cervix?. J C O Fall Educational Book:31-36, 1999.
14. Lanciano R, Thomas G, Eifel PJ. 20 Years of Progress in Radiation Oncology: Prostate Cancer. Semin Radiat Oncol 7(2):121-126, 1997. PMID: 10717206.
15. Eifel PJ. Adjuvant surgery after radiotherapy. J Natl Cancer Inst Monogr(21):85-8, 1996. PMID: 9023834.
16. Rotman M, Aziz H, Eifel PJ. Irradiation of Pelvic and Para-Aortic Nodes in Carcinoma of the Cervix. Semin Radiat Oncol 4(1):23-29, 1994. PMID: 10717086.
17. Eifel PJ. Problems with the Clinical Staging of Carcinoma of the Cervix. Semin Radiat Oncol 4(1):1-8, 1994. PMID: 10717083.
18. Woo S Eifel PJ. Evolution of radiation therapy in pediatric oncology. Cancer Bull 44:457-460, 1993.
19. Morris M, Eifel PJ, Wharton JT. Complications of therapy for cervical cancer. Cancer Bull 42:83-88, 1990.

Book Chapters

1. Eifel PJ. Adenocarcinoma of the Urethra. In: Rare Genitourinary Tumors. Springer: Switzerland, 2016.
2. Eifel PJ. Chemoradiotherapy: Neoadjuvant, Concomitant, Sequential, or Monomodality Treatment?. In: Textbook of Gynaecological Oncology. Gunes Publishing: Ankara, Turkey, 1405-1412, 2016.
3. Eifel PJ, Klopp AH, Berek JS, Konstantinopoulous PA. Cancer of the cervix, vagina, and vulva. In: DeVita, Hellman, and Rosenberg's Cancer Principles & Practice of Oncology. 10th. Wolters Kluwer Health: Philadelphia, 1013-1047, 2015.
4. Klopp AH, Eifel PJ. Uterus (Fallopian Tube, Cervix), Vagina and Vulva. In: ALERT - Adverse Late Effects of Cancer Treatment. Springer-Verlag: Berlin Heidelberg, 551-570, 2014.
5. Eifel P. Radiation Therapy. In: Berek & Hacker's Gynecologic Oncology. 6th. Wolters Kluwer: Philadelphia, 85-122, 2014.
6. Hacker NF, Eifel PJ. Vulvar Chancer. In: Berek & Hacker's Gynecologic Oncology. 6th. Wolters Kluwer: Philadelphia, 560-607, 2014.
7. Hacker NF, Eifel PJ. Vaginal Cancer. In: Berek & Hacker's Gynecologic Oncology. 6th. Wolters Kluwer: Philadelphia, 608-624, 2014.
8. Eifel PJ, Levenback C. Cervical Cancer. In: 60 Years of Survival Outcomes at the University of Texas MD Anderson Cancer Center. Springer: New York, 97-107, 2013.
9. Bhosale P, Kamat A, Eifel PJ. Ovarian Cancer. In: Oncologic Imaging. Elsevier: New York, 455-478, 2012.
10. Eifel PJ. A multidisciplinary approach to cancer: A radiation oncologist’s view. In: Oncologic Imaging. Elsevier: Philadelphia, PA, 17-24, 2012.
11. Eifel PJ, Berek JS, Markman MA. Cancer of the Cervix, Vagina, and Vulva. In: DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practices of Oncology. 9th. Lippincott, Williams & Wilkins: Philadelphia, PA, 1311-1344, 2011.
12. Eifel PJ. The Uterine Cervix. In: Radiation Oncology. 9th. Mosby: St. Louis, MO, 733-797, 2010.
13. Eifel PJ. The Vulva and Vagina. In: Radiation Oncology. 9th. Mosby: St. Louis, MO, 798-811, 2010.
14. Jhingran A, Eifel P. The Endometrium. In: Radiation Oncology. 9th. Mosby: St. Louis, 774-797, 2010.
15. Eifel PJ, Berek JS, Markman MA. Cancer of the cervix, vagina, and vulva. In: Principles and Practice of Oncology. 8th. Lippincott, Williams & Wilkins: Philadelphia, PA, 1496-1543, 2008.
16. Choi S, Eifel PJ. Cervical Cancer. In: J Natl Compr Canc Netw. 1. Jones Bartlett Publishers: Sudbury, MA, 14-36, 2008.
17. Karlan B, Markman M, Eifel PJ. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: Cancer. Principles and Practice of Oncology, 7th Edition. 7. Lippincott Williams & Wilkins: Philadelphia, PA, 1295-1341, 2007.
18. Eifel PJ. Integration of chemotherapy & radiation for cancer of the cervix. In: Choices in Advanced Radiotherapy. 1. Nucletron B.V: The Netherlands, 99-103, 2007.
19. Eifel PJ Burke TW. Contemporary treatment of vaginal and vulvar cancers. In: MD Anderson Cancer Care Series. Gynecologic Cancer. Springer-Verlag: New York, 64, 2006.
20. Jhingran A, Eifel PJ, Wharton JT, Tortolero-Luna G.. Neoplasms of the cervix. In: Cancer Medicine 7. B.C. Decker, Inc: London, 1497, 2006.
21. Gershenson DM, Kavanagh JJ, Eifel PJ, Silva EG.. Multidisciplinary care of patients with gynecologic cancers. In: MD Anderson Cancer Care Series. Gynecologic Cancer. Springer-Verlag: New York, 2006.
22. Jhingran A, Eifel PJ, Ramirez P.. Treatment of locally advanced cervical cancer. In: MD Anderson Cancer Care Series. Gynecologic Cancer. Springer-Verlag: New York, 102, 2006.
23. Eifel PJ. Radiation Therapy. In: Practical Gynecologic Oncology. 4th. Lippincott, Williams & Wilkins: Philadelphia, PA, 119-16, 2005.
24. Eifel PJ, Berek JS, Markman MA.. Cancer of the cervix, vagina, and vulva. In: Cancer. Principles and Practice of Oncology. 7th. Lippincott, Williams & Wilkins: Philadelphia, PA, 1295, 2005.
25. Karlan BY, Markman MA, Eifel PJ.. Ovarian cancer, peritoneal carcinoma, and fallopian tube carcinoma. In: Cancer. Principles & Practice of Oncology. 7th. Lippincott, Williams & Wilkins: Philadelphia, PA, 1364, 2005.
26. Eifel PJ. Intensity-modulated radiation therapy for carcinomas of the uterine cervix and endometrium. In: Image-Guided IMRT. Springer-Verlag: Berlin Heidelberg, 411, 2005.
27. Eifel PJ. Radiation Therapy. In: Berek & Hacker's Gynecologic Oncology. 5th. Lippincott, Williams & Wilkins: Philadelphia, PA, 83-120, 2005.
28. Eifel PJ Curtin J. Early-Stage Cervical Cancer. In: Gynecologic Cancer: Controversies in Management. Elsevier Science: Philadelphia, PA, 161-174, 2004.
29. Jhingran A, Eifel PJ, Wharton JT, Tortolero-Luna G. Neoplasms of the Cervix. In: Cancer Medicine 6; Vol 2. B. C. Decker, Inc: Ontario, 1779-1808, 2003.
30. Eifel PJ. The Role of Combined Chemotherapy and Radiation Therapy in the Treatment of Gynecologic Malignancies. In: Chemoradiation and Cancer Therapy. Humana Press: Totowa, NJ, 303-320, 2003.
31. Jhingran A Eifel PJ. The Endometrium. In: Radiation Oncology. 8. Mosby: St. Louis, MO, 724-742, 2003.
32. Eifel PJ. The Uterine Cervix. In: Radiation Oncology. 8. Mosby: St. Louis, MO, 681-723, 2003.
33. Eifel PJ. The Vulva and Vagina. In: Radiation Oncology. 8. Mosby: St. Louis, MO, 743-756, 2003.
34. Jones III HW, Averette H, Benedet JL, Copeland L, Eifel PJ, Gershenson DM, Grigsby P, Kurman R, Lewis H, Partridge E, Talley L, Taylor P, Whitney C. Vulva; Vagina; Cervix Uteri; Corpus Uteri; Fallopian Tube; Gestational Trophoblastic Tumors. In: AJCC Cancer Staging Manual, Sixth Edition. 6. Springer: New York, 249-299, 2002.
35. Jhingran A Eifel PJ. Radiation Therapy. In: Handbook of Gynecologic Oncology. 2nd. Martin Dunitz Ltd: London, 77-90, 2002.
36. Levenback C Eifel PJ. Late Complications of Radiation therapy. In: ACS Atlas of Oncology: Cervix, Vulva, and Vagina. B. C. Decker, Inc: Ontario, 251-267, 2001.
37. Jhingran A Eifel PJ. Radiation therapy for Invasive cervical cancer. In: ACS Atlas of Oncology: Cervix, Vulva, and Vagina. B. C. Decker, Inc: Ontario, 147-168, 2001.
38. Eifel PJ. Invasive cervical cancer. Staging and selection of therapy. In: ACS Atlas of Oncology: Cervix, Vulva, and Vagina. B. C. Decker, Inc: Ontario, 121-132, 2001.
39. Ozols R, Schwartz P, Eifel PJ. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: Cancer. Principles and Practice of Oncology. J.B. Lippincott Co: Philadelphia, PA, 1597-1632, 2001.
40. Muggia FM, Eifel PJ, Burke T. Gestational trophoblastic diseases. In: Cancer. Principles and Practice of Oncology. J.B. Lippincott Co: Philadelphia, PA, 1594-1596, 2001.
41. Eifel PJ, Berek J, Thigpen JT. Cancers of the uterine body. In: Cancer. Principles and Practice of Oncology. J.B. Lippincott Co: Philadelphia, PA, 1573-1593, 2001.
42. Burke T, Eifel PJ, Muggia FM. Cancer of the cervix, vagina, and vulva. In: Cancer. Principles and Practice of Oncology. J.B. Lippincott Co: Philadelphia, PA, 1526-1572, 2001.
43. Jhingran AJ Eifel PJ. The role of radiotherapy in the management of vulvar cancer. In: Cancer and Pre-Cancer of the Vulva. Edward Arnold Ltd: London, England, 120-134, 2000.
44. Petereit D, Eifel PJ, Thomas G. Cervix. In: Clinical Radiation Oncology. Churchill Livingstone Inc: New York, NY, 886-906, 2000.
45. Eifel PJ. Endometrial Cancer. In: Clinical Radiation Oncology: Indications, Techniques, and Results. A John Wiley & Sons, Inc: New York, NY, 441-459, 2000.
46. Burke T, Eifel PJ, McGuire W, Wilkinson EJ. Vulva. In: Gynecologic Oncology. Principles and Practice. J.B. Lippincott Co: Philadelphia, PA, 775-811, 2000.
47. Eifel PJ. Radiation therapy. In: Practical Gynecologic Oncology. J.B. Lippincott Co: Philadelphia, PA, 117-158, 2000.
48. Lankford S Eifel PJ. Principles of radiation therapy. In: Pediatric Surgical Oncology. W.B. Saunders Co: Philadelphia, PA, 89-107, 1998.
49. Ozols R, Schwartz P, Eifel PJ. Cancer of the ovary and fallopian tube. In: Cancer. Principles and Practice of Oncology. J.B. Lippincott Co: Philadelphia, PA, 1502-1540, 1997.
50. Muggia FM, Eifel PJ, Burke, T. Gestational trophoblastic diseases. In: Cancer. Principles and Practice of Oncology. J.B. Lippincott Co: Philadelphia, PA, 1499-1501, 1997.
51. Eifel PJ, Berek J, Thigpen JT. Cancer cervix, vagina, and vulva. In: Cancer. Principles and Practice of Oncology. J.B. Lippincott Co: Philadelphia, PA, 1433-1477, 1997.
52. Burke T, Eifel PJ, Muggia FM. Cancer of the uterine body. In: Cancer. Principles and Practice of Oncology. J.B. Lippincott Co: Philadelphia, PA, 1478-1498, 1997.
53. Burke T, Eifel PJ, McGuire W, Wilkinson EJ. Vulva. In: Gynecologic Oncology. Principles and Practice. J.B. Lippincott Co: Philadelphia, PA, 717-752, 1996.
54. Eifel PJ. Clinical intracavitary systems for treatment of gynecologic malignancies. In: Brachytherapy Physics. American Association of Physicists in Medicine: Madison, Wisconsin,, 411-426, 1995.
55. Eifel PJ. Vulvar carcinoma: radiotherapy or surgery for the lymphatics?. In: Front Radiat Ther Oncol, 218-225, 1994.
56. Eifel PJ. Can patients with regional metastases from endometrial carcinoma be cured with radiation therapy?. In: Frontiers of Radiation Therapy and Oncology. Karger: Basel, 196-203, 1994.
57. Eifel PJ. Vulvar carcinoma. Radiotherapy or surgery for the lymphatics?. In: Front Radiat Ther Oncol. Karger: Basel, 218-225, 1994.
58. Balch CM, Pellis NR, Morton DL, Eifel PJ, Brennan MF. Oncology. In: Principles and Practice of Surgery. 6. McGraw-Hill Inc: New York, 305-376, 1994.
59. Eifel PJ. Acute and chronic normal tissue effects and potential modification in pediatric radiation therapy. In: Radiation therapy in pediatric oncology. Springer-Verlag: Berlin, 13-55, 1994.
60. Eifel PJ. Radiation therapy for cervical carcinoma. In: Gynecology and Obstetrics. J.B. Lippincott Co: Philadelphia, PA, 1993.
61. Eifel PJ. Radiotherapy vs. radical surgery for gynecologic neoplasms: Carcinomas of the cervix and vulva. In: Organ Conservation in Curative Cancer Treatment. Frontiers of Radiation Therapy and Oncology. Karger: Basel, 130-142, 1993.
62. Hacker N, Eifel PJ, McGuire WP, Wilkinson EJ. Vulva. In: Gynecologic Oncology. Principles and Practice. Lippincott Co: Philadelphia, 537-566, 1992.
63. Smoron GL, Brady LW, Cox JD, Earle JD, Eifel PJ, Fountain KS, Garton G, Grigsby PW, McGee JL, Reddy S, Rotman M, Sagerman RH, Sause WT, Shafer JP, Stevens KR. Radiation Oncology Self-Assessment Program. In: Radiation Oncology Self-Assessment Program Volume XII,. Professional Evaluation Incorporated, 1991.
64. Tarbell NJ, Wallman J, Eifel PJ, Cassady JR. Results of definitive irradiation for optic gliomas. In: Biology of Brain Tumour. Martinus Nijoff Pub. Co, 1986.
65. Niloff JM, Eifel PJ, Bloomer W, Knapp RC. Endometrial Carcinoma. In: Gynecologic Oncology. Macmillan: New York, 1986.
66. Cassady JR, Eifel PJ, Belli JA. Progress and problems of the treatment of brainstem glioma, medulloblastoma, and craniopharyngioma in childhood. In: Radiation Oncology. Elsevier: New York, 1985.

Books (edited and written)

1. Eifel PJ, Klopp AH. Gynecologic Radiation Oncology: A Practical Guide. 1. Wolters Kluwer: Philadelphia, 2016.
2. PJ Eifel, DM Gershenson, JJ Kavanaugh, EG Silva. Gynecologic Cancer. In: MD Anderson Cancer Care Series. Ed(s) PJ Eifel, DM Gershenson, JJ Kavanaugh, EG Silva. 5. Springer: New York, 2006.
3. PJ Eifel and C Levenback. ACS Atlas of Oncology: Cervix, Vulva, and Vagina. B. C. Decker, Inc: Ontario, 2001.